Journal of Shandong University (Health Sciences) ›› 2025, Vol. 63 ›› Issue (6): 100-106.doi: 10.6040/j.issn.1671-7554.0.2025.0216
• Clinical Medicine • Previous Articles
LIU Kailin1*, GUO Ying1*, WANG Zhihao1, GENG Chong1, WANG Nana2
CLC Number:
| [1] Matikainen N, Pekkarinen T, Ryhanen EM, et al. Physio-logy of calcium homeostasis: an overview [J]. Endocrinol Metab Clin North Am, 2021, 50(4): 575-590. [2] Wong SK. A review of current evidence on the relationship between phosphate metabolism and metabolic syndrome [J]. Nutrients, 2022, 14(21): 4525. doi: 10.3390/nu14214525 [3] Tournis S, Makris K, Cavalier E, et al. Cardiovascular risk in patients with primary hyperparathyroidism [J]. Curr Pharm Des, 2020, 26(43): 5628-5636. [4] Rashid G, Bernheim J, Green J, et al. Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor [J]. Eur J Clin Invest, 2008, 38(11): 798-803. [5] 黄仕琼, 李利华. 甲状旁腺激素在心肌肥厚和纤维化中的作用机制 [J]. 医学综述, 2022, 28(10): 1879-1884. HUANG Shiqiong, LI Lihua. Role and mechanism of parathyroid hormone in myocardial hypertrophy and fibrosis [J]. Medical Recapitulate, 2022, 28(10): 1879-1884. [6] 易春秀, 张雯, 赵雅静, 等. 甲状旁腺素与心血管疾病的研究进展 [J]. 心脏杂志, 2025,(3): 329-333. YI Chunxiu, ZHANG Wen, ZHAO Yajing, et al. Progress in parathyroid hormone and cardiovascular disease [J]. Chinese Heart Journal, 2025,(3): 329-333. [7] Tomaschitz A, Ritz E, Pieske B, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease [J]. Cardiovasc Res, 2012, 94(1): 10-19. [8] Pepe J, Cipriani C, Sonato C, et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review [J]. Eur J Endocrinol, 2017, 177(6): R297-R308. [9] Fucile I, Mancusi C, Visco V, et al. Serum parathormone, vitamin D and cardiovascular risk factors and markers: a pilot study [J]. Nutr Metab Cardiovasc Dis, 2024, 34(10): 2298-2304. [10] Polyzos SA, Duntas L, Bollerslev J. The intriguing connections of leptin to hyperparathyroidism [J]. Endocrine, 2017, 57(3): 376-387. [11] Babic Leko M, Pleic N, Gunjaca I, et al. Environmental factors that affect parathyroid hormone and calcitonin levels [J]. Int J Mol Sci, 2021, 23(1): 44. doi: 10.3390/ijms23010044 [12] Shen M, Li Z, Lv D, et al. Seasonal variation and correlation analysis of vitamin D and parathyroid hormone in Hangzhou, Southeast China [J]. J Cell Mol Med, 2020, 24(13): 7370-7377. [13] Tobias DK, Luttmann-Gibson H, Mora S, et al. Association of body weight with response to vitamin D supplementation and metabolism[J]. JAMA Netw Open, 2023, 6(1): e2250681. doi:10.1001/jamanetworkopen.2022.50681 [14] Shapses SA, Lee EJ, Sukumar D, et al. The effect of obesity on the relationship between serum parathyroid hormone and 25-hydroxyvitamin D in women[J]. J Clin Endocrinol Metab, 2013, 98(5): E886-E890. [15] Reinehr T, de Sousa G, Alexy U, et al. Vitamin D status and parathyroid hormone in obese children before and after weight loss[J]. Eur J Endocrinol, 2007, 157(2): 225-232. [16] Bolland MJ, Grey AB, Gamble GD, et al. Association between primary hyperparathyroidism and increased body weight: a meta-analysis[J]. J Clin Endocrinol Metab, 2005, 90(3): 1525-1530. [17] Lopez I, Pineda C, Raya AI, et al. Leptin directly stimulates parathyroid hormone secretion[J]. Endocrine, 2017, 56(3): 675-678. [18] Grethen E, McClintock R, Gupta CE, et al. Vitamin D and hyperparathyroidism in obesity[J]. J Clin Endocrinol Metab, 2011, 96(5): 1320-1326. [19] Hoang D, Broer N, Sosa JA, et al. Leptin is produced by parathyroid glands and stimulates parathyroid hormone secretion[J]. Ann Surg, 2017, 266(6): 1075-1083. [20] Adam MA, Untch BR, Danko ME, et al. Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism[J]. J Clin Endocrinol Metab, 2010, 95(11): 4917-4924. [21] Dayyeni AA, Mahdi A, He YL, et al. Parathyroid gland weight is associated with high density lipoprotein levels in patients with primary hyperparathyroidism[J]. J Clin Transl Endocrinol, 2019, 19: 100213. doi:10.1016/j.jcte.2019.100213 [22] George JA, Norris SA, Toman M, et al. Visceral adiposity is a predictor of parathyroid hormone levels in healthy adults[J]. J Endocrinol Invest, 2016, 39(4): 447-453. [23] Ministrini S, Ricci MA, Daviddi G, et al. Determinants of high parathyroid hormone levels in patients with severe obesity and their relationship with the cardiometabolic risk factors, before and after a laparoscopic sleeve gastrectomy intervention[J]. Obes Surg, 2020, 30(6): 2225-2232. [24] Pitroda AP, Harris SS, Dawson-Hughes B. The association of adiposity with parathyroid hormone in healthy older adults[J]. Endocrine, 2009, 36(2): 218-223. [25] Jastrzbska J, Skalska M, Radzimiński Ł, et al. Changes of 25(OH)D concentration, bone resorption markers and physical performance as an effect of sun exposure, supplementation of vitamin D and lockdown among young soccer players during a one-year training season[J]. Nutrients, 2022, 14(3): 521. doi:10.3390/nu14030521 [26] He H, Zeng YP, Wang X, et al. Meteorological condition and air pollution exposure associated with vitamin D deficiency: a cross-sectional population-based study in China[J]. Risk Manag Healthc Policy, 2020, 13: 2317-2324. doi:10.2147/RMHP.S273145 [27] Kroll MH, Bi CX, Garber CC, et al. Temporal relationship between vitamin D status and parathyroid hormone in the United States[J]. PLoS One, 2015, 10(3): e0118108. doi:10.1371/journal.pone.0118108 [28] Danese VC, Pepe J, Ferrone F, et al. The mutual interplay between bone, glucose and lipid metabolism: the role of vitamin D and PTH[J]. Nutrients, 2023, 15(13): 2998. doi:10.3390/nu15132998 [29] Olejarz M, Szczepanek-Parulska E, Ruchala M. Lipoprotein alterations in endocrine disorders-a review of the recent developments in the field[J]. Front Endocrinol, 2024, 15: 1354098. doi:10.3389/fendo.2024.1354098 [30] Ahlström T, Hagström E, Larsson A, et al. Correlation between plasma calcium, parathyroid hormone(PTH)and the metabolic syndrome(MetS)in a community-based cohort of men and women[J]. Clin Endocrinol, 2009, 71(5): 673-678. [31] Karras SN, Koufakis T, Tsekmekidou X, et al. Increased parathyroid hormone is associated with higher fasting glucose in individuals with normocalcemic primary hyperparathyroidism and prediabetes: a pilot study[J]. Diabetes Res Clin Pract, 2020, 160: 107985. doi:10.1016/j.diabres.2019.107985 [32] Shimobayashi M, Albert V, Woelnerhanssen B, et al. Insulin resistance causes inflammation in adipose tissue[J]. J Clin Invest, 2018, 128(4): 1538-1550. [33] Sukumar D, Partridge NC, Wang X, et al. The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity[J]. J Clin Endocrinol Metab, 2011, 96(6): 1852-1858. [34] Frey S, Mirallié É, Cariou B, et al. Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: a narrative review[J]. Nutr Metab Cardiovasc Dis, 2021, 31(4): 981-996. [35] Chang E, Donkin SS, Teegarden D. Parathyroid hormone suppresses insulin signaling in adipocytes[J]. Mol Cell Endocrinol, 2009, 307(1/2): 77-82. [36] Sass MR, Wewer Albrechtsen NJ, Pedersen J, et al. Secretion of parathyroid hormone may be coupled to insulin secretion in humans[J]. Endocr Connect, 2020, 9(7): 747-754. [37] Al-Hraishawi H, Dellatore PJ, Cai XJ, et al. Intact parathyroid hormone levels and primary hyperparathyroidism[J]. Endocr Res, 2017, 42(3): 241-245. [38] Procopio M, Barale M, Bertaina S, et al. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms[J]. Endocrine, 2014, 47(2): 581-589. [39] OByrne SM, Blaner WS. Retinol and retinyl esters: biochemistry and physiology[J]. J Lipid Res, 2013, 54(7): 1731-1743. [40] Nono Nankam PA, Blüher M. Retinol-binding protein 4 in obesity and metabolic dysfunctions[J]. Mol Cell Endocrinol, 2021, 531: 111312. doi:10.1016/j.mce.2021.111312 [41] Wong CKM, Lai T, Holly JMP, et al. The effects of retinoic acid on the insulin-like growth factor axis in primary tissue culture from hyperparathyroidism[J]. World J Surg, 2006, 30(5): 714-720. [42] Liu W, Ridefelt P, Akerström G, et al. Differentiation of human parathyroid cells in culture[J]. J Endocrinol, 2001, 168(3): 417-425. [43] Hellman P, Liu W, Westin G, et al. Vitamin D and retinoids in parathyroid glands(review)[J]. Int J Mol Med, 1999, 3(4): 355-361. [44] Touvier M, Deschasaux M, Montourcy M, et al. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values[J]. J Clin Endocrinol Metab, 2014, 99(4): 1196-1203. [45] Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure, and vitamin D[J]. Calcif Tissue Int, 1995, 56(2): 104-108. [46] Serdar MA, Batu Can B, Kilercik M, et al. Analysis of changes in parathyroid hormone and 25(OH)vitamin D levels with respect to age, gender and season: a data mining study[J]. J Med Biochem, 2017, 36(1): 73-83. [47] Gong M, Wang K, Sun H, et al. Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone[J]. J Endocrinol Invest, 2023, 46(10): 2067-2077. [48] Jenks MZ, Fairfield HE, Johnson EC, et al. Sex steroid hormones regulate leptin transcript accumulation and protein secretion in 3T3-L1 cells[J]. Sci Rep, 2017, 7(1): 8232. doi:10.1038/s41598-017-07473-5 |
| [1] | LIU Wen, FENG Wenjuan, YANG Yang, JI Changli, CHAO Lan. Impact of BMI on cumulative birth rate in patients with normal ovarian response [J]. Journal of Shandong University (Health Sciences), 2024, 62(3): 54-60. |
| [2] | WANG Xinqi, XU Jingjing, XU Wangwang, ZHANG Yang, GAO Jin. Association of 25(OH)D, IGF-I, anxiety and depression symptoms with non-suicidal self-injury in outpatient adolescents with psychiatric disorders [J]. Journal of Shandong University (Health Sciences), 2024, 62(12): 59-64. |
| [3] | ZHAO Meiru, ZHU Di, LIU Lin, GUAN Qingbo, ZHANG Xu. Association of 4 simple insulin resistance indicators with the risk of hyperuricemia in 698 patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2022, 60(12): 44-51. |
| [4] | ZHENG Fengjie, SONG Yuwen, SUN Aili, PAN Zhe, WANG Dianhui, LOU Nengjun, LYU Li, ZHUANG Xianghua, CHEN Shihong. Correlation between diabetic peripheral neuropathy and sarcopenia [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 38-44. |
| [5] | LIU Xiaofei, LIANG Ying, ZHANG Congxi, WANG Juan, PAN Yun, XU Jiawei, CHANG Chun, DONG Liang. Association of serum leptin with induced sputum eosinophils in 92 asthmatic patients [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 27-33. |
| [6] | SONG Haixia,YUAN Caixia,FAN Lingling. Impact of body mass index on pregnancy outcomes in artificial insemination by husband [J]. Journal of Shandong University (Health Sciences), 2020, 58(1): 49-53. |
| [7] | JIANG Lijuan, LIU Fuqiang, JIANG Ziyun, LI Wenjuan, LIN Peng, WANG Chuan, HOU Xinguo, CHEN Li. Dapagliflozin improves lipid metabolism and visceral adipose tissues in overweight and obese patients with type 2 diabetes [J]. Journal of Shandong University (Health Sciences), 2019, 57(6): 87-93. |
| [8] | SHENG Xuan, WANG Yonge, GUO Dan, LAN Meng, FAN Fengjing, DING Hongyu. Effects of body mass index and renal subcutaneous depth on the results of virtual touch tissue imaging quantification in renal transplant patients [J]. Journal of Shandong University (Health Sciences), 2018, 56(12): 68-72. |
| [9] | MA Runmei, ZHANG Yi, WANG Yanwen, XU Dandan, SUN Zhiying, SHI Wanying, CUI Liangliang, LI Tiantian. A systematic review on association between particulate matter and blood glucose [J]. Journal of Shandong University (Health Sciences), 2018, 56(11): 27-33. |
| [10] | ZHANG Suping, WANG Ze, ZHOU Yali, LI Jing, LU Xilan, BAI Hongwei, SHI Yuhua. Clinical effects of body mass index on ovulation induction treatment with letrozole among women with polycystic ovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 81-85. |
| [11] | ZHANG Lin, LI Jing, WANG Ze, ZHANG Jiangtao, MA Zengxiang, SHI Yuhua. Impact of thyroid-stimulating hormone on blood glucose and serum lipids in patients with polycystic ovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 80-84. |
| [12] | PENG Li, QIANG Ye, ZHAO Huichen, CHEN Shihong, YAO Weidong, LIU Yuantao. Clinical studies on type 2 diabetic patients treated with sitagliptin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 60-63. |
| [13] | DU Tengfei, LIU Guoming, GUO Xiaomei, Ching-Chang Ko, SHANG Hongguo. Effects of PTH on gene ONC, OPN, C-FOS, COL1, VEGF, RUNX2 and ALP during the distraction osteogenesis in rat mandible [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 32-35. |
| [14] | PEI Leilei, SUN Zhonghua, LI Zhe, ZHAO Wenping. Effects of sitagliptin combined with high-dose insulin on type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 39-42. |
| [15] | CAI Yu, ZHANG Ying, XU Cheng. Prevention and nursing measures for renal osteopathy in patients with maintenance hemodialysis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(Z1): 154-155. |
|
||